Research
A shared molecular weakness in glioblastoma tumor cells may offer a new treatment target
The Brief
- Researchers at the Icahn School of Medicine at Mount Sinai identified a molecular trait shared across glioblastoma tumor cells.
- The trait resembles one used by immature cells during brain development.
- The finding may reveal a target for future glioblastoma treatments, but no treatment is described yet.
Why it matters
Glioblastoma is an aggressive adult brain cancer with limited treatment options, so a shared molecular weakness could point researchers toward new drug targets.
Who’s affected
- cancer researchers and neuro-oncology scientists
- patients with glioblastoma and their families
Researchers at the Icahn School of Medicine at Mount Sinai have identified a shared molecular trait in glioblastoma, an aggressive brain cancer in adults. It resembles one used by immature cells during brain development and may reveal a target for future treatments.